Insider / Natera, Inc.
Rubin Eric H
Director at Natera, Inc.
- Company
- Natera, Inc.
- Ticker
- NTRA
- First filing on record
- April 28, 2026
- Latest trade on record
- June 26, 2026
- SEC filings
- EDGAR ↗
Rubin Eric H, Director at Natera, Inc., has disclosed 3 transactions in NTRA since April 28, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed June 30, 2026, 4 days after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Rubin Eric H reported 3 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
1 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 3 | 2,204 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | Other A | June 26, 2026 | June 30, 2026 | 4d | 75 | — | — | Form 4 ↗ | ||
| NTRA | Other A | May 29, 2026 | June 3, 2026 | 5d | 2,124 | — | — | late | Form 4 ↗ | |
| NTRA | Other A | April 24, 2026 | April 28, 2026 | 4d | 5 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 30, 2026 | Form 4 | 0001867204-26-000009 | 1 | published | EDGAR ↗ |
| June 3, 2026 | Form 4 | 0001867204-26-000008 | 1 | published | EDGAR ↗ |
| April 28, 2026 | Form 4 | 0001867204-26-000007 | 1 | published | EDGAR ↗ |
Other insiders at Natera, Inc.
- Sheena Jonathan Director 168 rows
- Rabinowitz Matthew EXECUTIVE CHAIRMAN 127 rows
- BOTHA ROELOF Director 87 rows
- Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS 78 rows
- Chapman Steven Leonard CEO AND PRESIDENT 74 rows
- RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER 55 rows
- Brophy Michael Burkes CHIEF FINANCIAL OFFICER 53 rows
- Fesko John PRESIDENT, CHIEF BUS. OFFICER 23 rows
- Baynes Roy D. Director 19 rows
- Chapman Rowan E Director 13 rows
Everyone on file, with contracts and lobbying under the company's name: Natera, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 3 | April 28, 2026 | June 30, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.